Altabrisa Group
Providing exceptional GXP consulting services with a customized approach and global reach
Providing exceptional GXP consulting services with a customized approach and global reach
Altabrisa Group is a consultancy company that focuses on pharmaceuticals, medical devices, and biotechnology, offering exceptional GXP consulting services with a customized approach and global reach. Despite being a small consultancy and management firm, Altabrisa Group offers a comprehensive range of quality and regulatory compliance services, including quality and compliance audits, pre-approval inspection preparation, as well as process, utility, computer, and facility validation. Additionally, they provide CMC analytical, formulation, manufacturing, and quality services. The company received a substantial £940.00K Series C investment from Angel CoFund, The North West Fund, Newable Private Investing, and Angels in MedCity on 08 April 2014. With its strong focus on the pharmaceutical industry, Altabrisa Group is well-positioned to capitalize on the increasing demand for GXP consulting services in this sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | £940.00K | 4 |
|
08 Apr 2014 |
| Series B | £300.00K | - | 20 Apr 2012 | |
| Venture Round | £210.00K | 1 |
|
20 Nov 2011 |
No recent news or press coverage available for Altabrisa Group.
We care about your data, and we'd love to use cookies make your experience better.
